NCT00786825View on ClinicalTrials.gov

Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Type 1 Diabetes
Interventions
DRUG

somatostatin

Somatostatin may be used to suppress endogenous insulin secretion

Trial Locations (1)

55414

University of Minnesota, Minneapolis

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT00786825 - Measurement of Glucose/Glycogen Metabolism in Humans Using Magnetic Resonance at 4 or 7 Tesla | Biotech Hunter | Biotech Hunter